News Industry News New Haven Pharmaceuticals Presents Positive Data That Shows DURLAZA™ is Well Tolerated and Delivers Sustained 24-hour Antiplatelet Control March 01, 2016
News Industry News Regeneron and Sanofi Announce 18,000-Patient ODYSSEY OUTCOMES Trial of Praluent® Injection Fully Enrolled November 23, 2015
News Industry News New Haven Pharmaceuticals Receives FDA Approval for DURLAZA™ (aspirin) Extended Release Capsules for Secondary Prevention of Stroke and Acute Cardiac Events September 08, 2015
News Industry News Abbott Initiates ABSORB IV Trial to Evaluate Quality of Life and Cost Savings of Dissolving Heart Device September 15, 2014
News Industry News ABSORB II Study Shows Abbott's Dissolving Heart Device Comparable to the World's Leading Heart Stent September 14, 2014
News Industry News Two Year Data from FAME 2 Trial Shows Sustained Benefits of FFR-Guided PCI over Medical Treatment in Patients with Stable CAD September 02, 2014
News Industry News New Clinical Trial Results Demonstrate Importance of St. Jude Medical Fractional Flow Reserve in Guiding Treatment of NSTEMI Patients September 01, 2014
News Industry News CardioDx Announces Aetna and Coventry Health Coverage for Corus® CAD Gene Expression Test July 07, 2014
News Industry News POST-IT Clinical Registry Demonstrates Importance of St. Jude Medical Fractional Flow Reserve Technology at EuroPCR 2014 May 22, 2014
News Industry News Study Demonstrates High Accuracy of Non-Invasive Computed FFR in Evaluating October 30, 2013
News Industry News FFR-Guided PCI Demonstrates Cost-Effectiveness When Compared to Medical Therapy for Stable Coronary Artery Disease October 24, 2012
News Industry News Volcano Announces Global Launch of PrimeWire Prestige® PLUS Pressure Guide Wire with AcuSense™ Technology October 23, 2012
News Industry News CardioDx Announces Medicare Coverage for Corus CAD Gene Expression Test for the Diagnosis of Obstructive Coronary Artery Disease August 08, 2012
News Industry News Patients with ACS and/or diabetes who show poor response to dual antiplatelet therapy November 08, 2011
News Industry News St. Jude Medical Begins U.S. Trial Studying ST Segment Monitoring Technology August 31, 2011